587
Views
0
CrossRef citations to date
0
Altmetric
Theme: Parkinson's disease - Editorial

Developing predictive biomarkers for dementia of Parkinson’s disease

&
Pages 1661-1663 | Published online: 09 Jan 2014

References

  • Biomarkers Definitions Working Group. Biomarker and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmcol. Ther.69, 89–95 (2001).
  • Caviness JN, Lue L, Adler CH, Walker DG. Parkinson’s disease dementia and potential therapeutic strategies. CNS Neurosci. Ther.17(1), 32–44 (2011).
  • Johansen KK, White LR, Sando SB, Aasly JO. Biomarkers: Parkinson’s disease with dementia and dementia with Lewy bodies. Parkinsonism Relat. Disord.16(5), 307–315 (2010).
  • Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P. Risk of dementia in Parkinson’s disease. Neurology56, 730–736 (2001).
  • Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease. Arch. Neurol.60, 387–392 (2003).
  • Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov. Disord.20, 1255–1263 (2005).
  • Hobson P, Meara J. Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov. Disord.19, 1043–1049 (2004).
  • Hughes TA, Ross HF, Musa S et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology54, 1596–1602 (2000).
  • Janvin C, Aarsland D, Larsen JP, Hugdahl K. Neuropsychological profile of patients with Parkinson’s disease without dementia. Dement. Geriatr. Cogn. Disord.15, 126–131 (2003).
  • Caviness JN, Driver-Dunckley ED, Connor DJ et al. Defining mild cognitive impairment in Parkinson’s disease. Mov. Disord.22(9), 1272–1277 (2007).
  • Burton EJ, McKeith IB, Burn DJ, Williams ED, O’Brien JT. Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain127, 791–800 (2004).
  • Beyer MK, Janvin CC, Larsen JP. A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry. J. Neurol. Neurosurg. Psychiatry78, 254–259 (2007).
  • Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology70, 1470–1477 (2008).
  • Siderowf A, Xie SX, Hurtig H et al. CSF amyloid β1-42 predicts cognitive decline in Parkinson disease. Neurology75, 1055–1061 (2010).
  • Caviness JN, Hentz JG, Evidente VGH et al. Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson’s disease. Parkinsonism Relat. Disord.13, 348–354 (2007).
  • Klassen B, Hentz J, Shill H et al. Quantitative electroencephalography as a predictor for Parkinson’s disease dementia. Neurology77, 118–124 (2011).
  • Grund B, Sabin C. Analysis of biomarker data: logs, odds ratio, and receiver operating curves. Curr. Opin. HIV AIDS5(6), 473–479 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.